Literature DB >> 16957780

Antiviral action of the tumor suppressor ARF.

María A García1, Manuel Collado, César Muñoz-Fontela, Ander Matheu, Laura Marcos-Villar, Javier Arroyo, Mariano Esteban, Manuel Serrano, Carmen Rivas.   

Abstract

Oncogenic viruses frequently target the pathways controlled by tumor suppressor genes, suggesting an extra function for these proteins as antiviral factors. The control exerted by the tumor suppressor Arf on cellular proliferation is crucial to restrict tumor development; however, a potential contribution of Arf to prevent viral infectivity has remained unexplored. In the present study, we investigated the consequences of loss or increased expression of Arf on viral infection. Our results reveal that ARF expression is induced by interferon and after viral infection. Furthermore, we show that ARF protects against viral infection in a gene dosage-dependent manner, and that this antiviral action is mediated in part by PKR through a mechanism that involves ARF-induced release of PKR from nucleophosmin complexes. Finally, Arf-null mice were hypersensitive to viral infection compared to wild-type mice. Together, our results reveal a novel and unexpected role for the tumor suppressor ARF in viral infection surveillance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16957780      PMCID: PMC1570439          DOI: 10.1038/sj.emboj.7601302

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  53 in total

1.  Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.

Authors:  P S Moore; C Boshoff; R A Weiss; Y Chang
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

Review 2.  The cat and mouse games that genes, viruses, and cells play.

Authors:  R A Weinberg
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

3.  Role of the INK4a locus in tumor suppression and cell mortality.

Authors:  M Serrano; H Lee; L Chin; C Cordon-Cardo; D Beach; R A DePinho
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

Review 4.  p53 and tumour viruses: catching the guardian off-guard.

Authors:  J C Neil; E R Cameron; E W Baxter
Journal:  Trends Microbiol       Date:  1997-03       Impact factor: 17.079

5.  Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.

Authors:  T Kamijo; F Zindy; M F Roussel; D E Quelle; J R Downing; R A Ashmun; G Grosveld; C J Sherr
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

6.  ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

Authors:  Y Zhang; Y Xiong; W G Yarbrough
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

7.  The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

Authors:  J Pomerantz; N Schreiber-Agus; N J Liégeois; A Silverman; L Alland; L Chin; J Potes; K Chen; I Orlow; H W Lee; C Cordon-Cardo; R A DePinho
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

8.  Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein.

Authors:  M K Chelbi-Alix; F Quignon; L Pelicano; M H Koken; H de Thé
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

9.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

10.  Cell cycle phase-dependent changes of localization and oligomerization states of nucleophosmin / B23.

Authors:  Y H Chou; B Y Yung
Journal:  Biochem Biophys Res Commun       Date:  1995-12-05       Impact factor: 3.575

View more
  18 in total

1.  An atlas of soybean small RNAs identifies phased siRNAs from hundreds of coding genes.

Authors:  Siwaret Arikit; Rui Xia; Atul Kakrana; Kun Huang; Jixian Zhai; Zhe Yan; Oswaldo Valdés-López; Silvas Prince; Theresa A Musket; Henry T Nguyen; Gary Stacey; Blake C Meyers
Journal:  Plant Cell       Date:  2014-12-02       Impact factor: 11.277

Review 2.  Are macrophages in tumors good targets for novel therapeutic approaches?

Authors:  Samthosh V Alahari; Shengli Dong; Suresh K Alahari
Journal:  Mol Cells       Date:  2014-12-16       Impact factor: 5.034

Review 3.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

4.  ORF73-null murine gammaherpesvirus 68 reveals roles for mLANA and p53 in virus replication.

Authors:  J Craig Forrest; Clinton R Paden; Robert D Allen; Julie Collins; Samuel H Speck
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

5.  Deficiency of the multi-copy mouse Y gene Sly causes sperm DNA damage and abnormal chromatin packaging.

Authors:  Jonathan M Riel; Yasuhiro Yamauchi; Atsushi Sugawara; Ho Yan J Li; Victor Ruthig; Zoia Stoytcheva; Peter J I Ellis; Julie Cocquet; Monika A Ward
Journal:  J Cell Sci       Date:  2012-11-23       Impact factor: 5.285

Review 6.  Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.

Authors:  M A García; J Gil; I Ventoso; S Guerra; E Domingo; C Rivas; M Esteban
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

7.  Tumor suppressor ARF: The new player of innate immunity.

Authors:  Paqui G Través; Alfonso Luque; Sonsoles Hortelano
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

8.  Role of the tumor suppressor ARF in macrophage polarization: Enhancement of the M2 phenotype in ARF-deficient mice.

Authors:  Sandra Herranz; Paqui G Través; Alfonso Luque; Sonsoles Hortelano
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

9.  Activation of NF-kB pathway by virus infection requires Rb expression.

Authors:  Maria A Garcia; Pedro Gallego; Michela Campagna; José González-Santamaría; Gloria Martínez; Laura Marcos-Villar; Anxo Vidal; Mariano Esteban; Carmen Rivas
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

Review 10.  Macrophages, inflammation, and tumor suppressors: ARF, a new player in the game.

Authors:  Paqui G Través; Alfonso Luque; Sonsoles Hortelano
Journal:  Mediators Inflamm       Date:  2012-12-18       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.